Taking into consideration that impaired insulin signalling in the brain is heavily associated with Alzheimer’s disease [69,70,71,72,73,74], affecting levels of this hormone may improve a patient’s condition. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.